DLG4 and myeloid sarcoma: However, the levels of PSD95 mRNA between the CRS and MS + CRS groups showed no significant difference; although the results from the MS + CRS group showed a trend toward a reduction compared with the CRS group, this difference did not reach statistical significance (P > 0.05).